Both atherosclerotic lesions and hypoxia alter the contractile properties of the arterial wall and, in particular, may interfere with the relaxation mechanisms dependent or not on the endothelium. The present study was designed to test the effect of severe hypoxia on the contractile behavior of the atherosclerotic rabbit aorta. Segments of aortas obtained from control, cholesterol-fed, or Watanabe hereditary hyperlipidemic rabbits were mounted in organ chambers for isometric tension recording. A change of the bath P02 from "normoxic" conditions (95% 02-5% C02) to "hypoxic" conditions (95% N2-5% C02) caused relaxation in the precontracted control aortas (by approximately 85%) but a transient contraction (approximately 20%o of the maximal contraction obtained with 30 mM KCI) followed by a relaxation in the precontracted atherosclerotic aortas. Both types of responses were observed in aortas contracted with aggregating platelets, 5-hydroxytryptamine (5-HT), norepinephrine, endothelin, and prostaglandin F2a,. The hypoxic contractions in atherosclerosis were not dependent on the presence of an intact endothelium. They could not be antagonized by blockers of a-adrenoceptors, 5-HT2 receptors, histamine receptors, thromboxane receptors, and muscarinic cholinoreceptors. Inhibitors of cyclooxygenase, lipoxygenase, Na+, K+-ATPase, and free radical scavengers or an activator of endothelium-derived relaxing factor did not significantly affect the hypoxic contraction; the absence of effect of some inhibitors of protein synthesis seems to rule out the involvement of endothelin, angiotensin II, and bradykinin. The hypoxic contraction was not influenced by omission of Ca21 from the medium or by inhibition of Ca2+ influx but was prevented by blockade of intracellular Ca2+. The inhibitor of nitric oxide synthase (nitro-L-arginine, 100 p.M) and the guanylyl cyclase inhibitor (methylene blue, 10 ,uM) both enhanced the initial contractile responses to 5-HT to a similar extent as hypoxia and completely prevented the hypoxic contraction in the atherosclerotic tissues. The cyclic nucleotide analogues 8-bromo-cGMP and dibutyryl cAMP also inhibited the hypoxic contraction in the atherosclerotic aorta. The cGMP levels were markedly decreased and the cAMP levels were moderately decreased in the aortas of the cholesterol-fed rabbits as compared with the control aortas. Hypoxia further decreased cGMP but not the cAMP levels in atherosclerotic aortas with and without endothelium. Our data thus demonstrate the occurrence of an unusual vasoconstrictor response in atherosclerotic arteries; this constrictor response depends on the availability of intracellular Ca2' and seems to be due to the further inhibition of an already impaired cGMP production. The latter reduction most likely results from inhibition of nitric oxide synthase present in nonendothelial cells of the atherosclerotic blood vessels. (Circulation Research 1993;72:616-630) A series of studies using isolated blood vessels and organs have illustrated that atherosclerosis can profoundly modify the arterial tone. Thus, in isolated arteries of hypercholesterolemic animals, a supersensitivity to the contractile action of 5-hydroxytryptamine (serotonin [5-HT]) and a decreased responsiveness to norepinephrine have been reported (for review see Reference 1). Furthermore, developing atherosclerotic lesions will progressively decrease the relaxation capacity of isolated human and animal arteries.
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Both atherosclerotic lesions and hypoxia alter the contractile properties of the arterial wall and, in particular, may interfere with the relaxation mechanisms dependent or not on the endothelium. The present study was designed to test the effect of severe hypoxia on the contractile behavior of the atherosclerotic rabbit aorta. Segments of aortas obtained from control, cholesterol-fed, or Watanabe hereditary hyperlipidemic rabbits were mounted in organ chambers for isometric tension recording. A change of the bath P02 from "normoxic" conditions (95% 02-5% C02) to "hypoxic" conditions (95% N2-5% C02) caused relaxation in the precontracted control aortas (by approximately 85%) but a transient contraction (approximately 20%o of the maximal contraction obtained with 30 mM KCI) followed by a relaxation in the precontracted atherosclerotic aortas. Both types of responses were observed in aortas contracted with aggregating platelets, 5-hydroxytryptamine (5-HT), norepinephrine, endothelin, and prostaglandin F2a,. The hypoxic contractions in atherosclerosis were not dependent on the presence of an intact endothelium. They could not be antagonized by blockers of a-adrenoceptors, 5-HT2 receptors, histamine receptors, thromboxane receptors, and muscarinic cholinoreceptors. Inhibitors of cyclooxygenase, lipoxygenase, Na+, K+-ATPase, and free radical scavengers or an activator of endothelium-derived relaxing factor did not significantly affect the hypoxic contraction; the absence of effect of some inhibitors of protein synthesis seems to rule out the involvement of endothelin, angiotensin II, and bradykinin. The hypoxic contraction was not influenced by omission of Ca21 from the medium or by inhibition of Ca2+ influx but was prevented by blockade of intracellular Ca2+. The inhibitor of nitric oxide synthase (nitro-L-arginine, 100 p.M) and the guanylyl cyclase inhibitor (methylene blue, 10 ,uM) both enhanced the initial contractile responses to 5-HT to a similar extent as hypoxia and completely prevented the hypoxic contraction in the atherosclerotic tissues. The cyclic nucleotide analogues 8-bromo-cGMP and dibutyryl cAMP also inhibited the hypoxic contraction in the atherosclerotic aorta. The cGMP levels were markedly decreased and the cAMP levels were moderately decreased in the aortas of the cholesterol-fed rabbits as compared with the control aortas. Hypoxia further decreased cGMP but not the cAMP levels in atherosclerotic aortas with and without endothelium. Our data thus demonstrate the occurrence of an unusual vasoconstrictor response in atherosclerotic arteries; this constrictor response depends on the availability of intracellular Ca2' and seems to be due to the further inhibition of an already impaired cGMP production. The latter reduction most likely results from inhibition of nitric oxide synthase present in nonendothelial cells of the atherosclerotic blood vessels. (Circulation Research 1993; 72:616-630) KEY WoRDs * hypoxic contraction * endothelium-dependent responses * hypercholesterolemia platelet-induced contraction * endothelin * cAMP * cGMP A series of studies using isolated blood vessels and organs have illustrated that atherosclerosis can profoundly modify the arterial tone. Thus, in isolated arteries of hypercholesterolemic animals, a supersensitivity to the contractile action of 5-hydroxytryptamine (serotonin ) and a decreased responsiveness to norepinephrine have been reported (for review see Reference 1) . Furthermore, developing atherosclerotic lesions will progressively decrease the relaxation capacity of isolated human and animal arteries.
One of the processes to be lost is the endotheliumdependent relaxation; indeed, as the lesions develop, the endothelium-derived relaxing factor (EDRF)-nitric oxide (NO) pathway of muscle relaxation activated by a variety of vasodilators such as acetylcholine or 5-HT becomes inactivated by a multifactorial time-dependent effect of the atherosclerosis.1-' The absence of this important dilatation mechanism may explain the unusual constrictor properties observed with acetylcholine and 5-HT, for example, in the atherosclerotic human coronary circulation. [12] [13] [14] [15] Tissue hypoxia is a consequence of obstructive narrowing of the arterial wall after the development of atherosclerotic plaques and eventually the formation of a thrombus (see Reference 16) . Hypoxia also profoundly alters the contractile properties of the vascular wall. Depending on the tissue, the species, and the hypoxic conditions imposed, both hypoxic contractions and relaxations (endothelium dependent or not) have been reported. 17 The altered arterial reactivity in atherosclerosis (enhancement of constrictor responses or absence of dilator responses) probably is a major contributor to vasospasm, which is more prominent in atherosclerotic blood vessels (see Reference 18) . Hypoxia may be a consequence of vasospasm; however, in tissues in which it causes constriction, hypoxia could also be a cause of vasospasm.
To our knowledge, the effect of atherosclerosis on the arterial responsiveness to hypoxia has not yet been studied. Therefore, we set up the present investigation with three major goals: 1) to compare the reactivity of a control and an atherosclerotic arterial wall to conditions of severe hypoxia, 2) to document any possible abnormal response noted in atherosclerosis, and 3) to characterize, if possible, the nature of such a response with special reference to NO and second-messenger systems.
Materials and Methods
For the present study, we used one group of Watanabe hereditary hyperlipidemic (WHHL) rabbits'9 aged between 8 and 20 months and purchased from the Centre de Production Animale, Olivet, France, and two groups of male New Zealand rabbits obtained from Charles River, France. The New Zealand rabbits were fed either a control diet or a diet containing cholesterol for 20 weeks. All animals received 200 g food daily. The diets were obtained from the L. Pietrement ets., France; the atherogenic diet was prepared by adding 0.30 g cholesterol to 100 g control diet, resulting in a final cholesterol content of 0.30±0.02% (four determinations performed by Les Laboratoires des Agriculteurs de France). For the total study, four WHHL rabbits, 24 control rabbits, and 39 cholesterol-fed rabbits were used. The protocol was identical to that described previously. 34 During the experimental period, the increase in body weight of the atherosclerotic New Zealand rabbits was slightly less than that of the control New Zealand rabbits, resulting in final body weights averaging 4.3 ±0.1 kg for the control rabbits and 3.8 +0.1 kg for the cholesterol-fed rabbits. The cholesterol diet markedly increased the plasma levels of total cholesterol from 29+3 to 1,065±80 mg/dl, increased those of high density lipoprotein cholesterol from 12±1 to 25±3 mg/dl but did not alter the triglyceride levels: 93±11 versus 139±18 mg/dl (n=15). At the time of the experiments, the WHHL rabbits weighed 3.7±+0.2 kg, and their plasma cholesterol content averaged 446±71 mg/dl (n=4).
Tissue Preparation
After the 20-week period, the New Zealand rabbits were anesthetized with sodium pentobarbital (30 mg/kg i.v.), and the left carotid artery of each rabbit was cannulated. A blood sample was taken for the determination of the plasma levels of total cholesterol, high density lipoprotein cholesterol, and triglycerides. The WHHL rabbits were treated in a similar way, and a plasma sample was taken for the determination of total cholesterol. From some rabbits, a second blood sample was collected into siliconized test tubes containing The rabbits were then killed, and segments of the thoracic aortas were carefully removed and immediately immersed in physiological salt solution (PSS) of the following composition (mM): NaCI 118.3, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25.0, Ca-EDTA 0.026, and glucose 11.1. The vessels were cut into rings 3 mm wide, taking special care not to touch their luminal surface; in some experiments, the endothelium was removed by gently rubbing the luminal surface with a forceps. Unless otherwise stated, the arterial rings used contained the endothelium.
Platelet Preparation
The blood samples collected on trisodium citrate (3.8%) were immediately centrifuged at 250g for 20 minutes to obtain platelet-rich plasma. Washed platelets were obtained by centrifuging platelet-rich plasma at 1,OO0g for 15 minutes; the pellet was once washed with a solution containing NaCI (135 mM), Tris-HCI (12 mM), EDTA (1.54 mM), and gelatin (0.2%), and then the preparation was centrifuged at 1,000g for 15 minutes. Finally, the platelets were resuspended in a PSS without Ca +.20
Organ Chamber Experiments
Segments of the aortas were mounted in organ chambers (20 ml) filled with oxygenated PSS maintained at 37°C (see Reference 3) . Isometric tension was monitored continuously using force transducers (Celaster, Lusignan, France) connected to a data acquisition system (Moise 2, Celaster).
The oxygen tension of the organ baths was recorded by means of an oxygen probe connected to a biological oxygen monitor (Yellow Springs Instrument Co., Yellow Springs, Ohio). This instrument was calibrated using a series of gases with different oxygen tensions (UCAR, France) and a reducing agent, sodium dithionite (Na2S204, 10 mM). In our experiments, switching from the control (95% 02) to the hypoxic (0% 02) solution caused rapid reproducible changes in oxygen pressure correlating with the percentage of oxygen indicated by the gas company. The oxygen concentration in the organ chamber reached 15% within 30 seconds (time point for changes in isometric tension) and reached 6% within 2 minutes (time point of maximal contraction in atherosclerosis; see "Results").
After equilibration in control conditions (95% 02) for 30 minutes, the aortic tissues were placed stepwise under 8 g initial tension; previous studies showed that this is the optimal resting tension for both control and atherosclerotic aortas.34 After a 1-hour equilibration period, during which the tissues were washed regularly and the basal tension was readjusted to optimal tension, the preparations were exposed to an augmented K' concentration (30 mM) by increasing the KCl concentration of the bath solution. Once the contractions to high KCl were stable, a return to control conditions was achieved by repeatedly overflowing the organ chambers with fresh PSS. When necessary for the sake of comparison, the contractile response (e.g., those to hypoxia) was expressed as a percentage of this initial contraction to KCI. The initial KCI-induced contractions (n=30) averaged 7.51±0.70 and 6.43+0.45 g in control aortas with and without endothelium, respectively, and 5.62+0.69 and 5.11+±0.64 g in atherosclerotic aortas trisodium citrate (3.8%) for the platelet preparation.
with and without endothelium, respectively. Although the values tended to be lower in the atherosclerotic aortas, the differences were not significant.
In most cases, each ring was then contracted with an agonist (norepinephrine, platelets, 5-HT, endothelin-1 [ET-1], or prostaglandin F2a [PGF2aI). When the contractile responses to the agonists had stabilized, rapid switching from normoxia (95% 02-5% C02) to hypoxia (95% N2-5% C02) was induced to test the hypoxic response of the preparations. After 30 minutes of hypoxia, the bath solution was reoxygenated.
In aortas of the control rabbits, the presence or absence of the endothelium was checked after return of the control response by determining whether acetylcholine (0.3 gM) had caused relaxation. In 12 control tissues with endothelium, the concentration of acetylcholine used evoked relaxations that averaged 83.9±3.9% of the initial contraction; removal of the endothelium reduced the relaxation to 2.2±1.1%. In the atherosclerotic aortas, the relaxations to acetylcholine were nearly absent in the presence (15.8±5.5%, n=19) and abolished in the absence (0%, n=8) of the endothelium.
After this first response, the preparations were repeatedly washed for a 1-hour period. The rings were then again contracted with the agonists, either in control conditions or in the presence of inhibitors or antagonists administered at least 30 minutes earlier.
In each series of experiments, one segment always served as a reference to determine any possible variation with time of the tissue response to hypoxia. In some experiments, the effect of hypoxia on basal tension was tested; switching from normoxic conditions to hypoxic conditions was then performed in the absence of contractile agents.
To study the influence of a decreased Ca 2+ concentration, "calcium-free" medium was used by preparing PSS containing EGTA (0.1 mM) from which Ca2+ was omitted. effect of hypoxia on cyclic nucleotide levels was evaluated after 30 seconds, 3 minutes, and 30 minutes in different rings obtained from the same aorta. In some tissues studied under normoxic conditions, forskolin (10 ,M), nitroglycerin (1 ,M), or acetylcholine (1 ,M) was added 15 minutes after norepinephrine. The effect of these vasodilators on cyclic nucleotide levels was evaluated 3 minutes later. The endothelium was removed from some rings, as described above, before experimentation; the cyclic nucleotide levels in these tissues were determined in the presence of norepinephrine as for the vessels with endothelium.
The tissue levels of cAMP and cGMP were measured by a method slightly modified from that described by Bigaud et al.22 Briefly, the incubations were terminated by freeze clamping the aortas with stainless-steel tongs precooled in liquid nitrogen. The rings were then homogenized for 2 minutes using a glass potter homogenizer that contained 1 ml assay buffer (acetate, 50 mM; pH 5.8) in the presence of theophylline (1 mM) to prevent any possible cyclic nucleotide degradation by phosphodiesterases. This homogenization was followed by a 30-second sonication period.
An aliquot of the final homogenate was used for protein determination by following the method described by Schacterle and Pollack23 after a 12-hour preincubation in NaOH (2N). The remaining homogenate was centrifuged at 10,000g for 5 minutes, and the content of both cAMP and cGMP was then assayed by the radioimmunochemical method using commercially available kits (Amersham RPA 509 for cAMP and New England Nuclear NEX 133 for cGMP). The final levels of cyclic nucleotides are expressed as picomoles per gram protein. The protein content of the control aortas averaged 75±5 mg/g (n=32); that of the atherosclerotic aortas averaged 84±4 mg/g (n=64).
CONTROL

Examination of the Atherosclerotic Lesions
The rings used in the organ chambers were, after completion of the experiments, cut open longitudinally, and their intimal surface was investigated for the occurrence of fatty streaks. These fatty streaks were evaluated on a scale from 0 to 5; an aortic segment that did not have visible streaks was given a score of 0, and a segment that was completely covered with fatty streaks was given a score of 5.3,21 Mean values were calculated to obtain one score per animal. None of the control aortas showed any sign of fatty streaks; the aortas of the cholesterol-fed rabbits received a mean score of 4.0±0.1 (n=28), indicating that approximately 80% of their intimal surface was covered with lesions.4 The aortas of the WHHL rabbits had a mean score of 3.2±0.7 (n=4), indicating that approximately 64% of their intimal surface was covered with lesions.
Determination of Cyclic Nucleotide Levels
Rabbit thoracic aorta rings with endothelium were prepared as described above for the organ chamber experiments. The rings were incubated in 2 ml oxygenated PSS (95% 02) during an equilibration period of 60 minutes. Norepinephrine (0.3 ,uM) was then added to the tissues, and after 15 minutes, rapid switching from normoxia to hypoxia (95% N2) was performed. The . Bar graphs showing that hypoxia only causes relaxations during contractions caused by norepinephrine in aortas obtained from control rabbits. These relaxations were slightly but not significantly reduced by removal of the endothelium. In aortas obtained from cholesterol-fed rabbits, hypoxia causes an immediate reversible contraction followed by relaxation; neither the contraction nor the relaxation is modified by mechanical removal of the endothelium. The relaxations to hypoxia in the atherosclerotic aortas are significantly less than those noted in the control aortas. The control responses (100%) to norepinephrine average 7.3±0.7 and 7.3±1.1 g for control aortas with endothelium (+E) and without endothelium (-E), respectively, and 2.7±0.5 and 2.1±0.5 g for the atherosclerotic +E and -E aortas, respectively; n=6 in each group. Open bars indicate normoxia (95% 02). Solid bars indicate the initialphase of the hypoxia (just before the relaxation, between 2 and 4 minutes in control tissues; and time to reach the maximal contraction, between 2 and 5 minutes in the atherosclerotic tissues). Hatched bars indicate the late phase of the hypoxia (30 minutes). Solid asterisks indicate that the decrease in tension is significant (p<0.05 by Student's t test for paired observations). Solid stars indicate that the augmentation of contraction is significant (p<0.05 by Student's t test for paired observations). Open asterisks indicate that the decrease in tension is less than that noted in the corresponding control aortas (p<0.05 by Student's t test for unpaired observations).
Drugs
The following pharmacological agents were used: acetylcholine chloride, L-arginine hydrochloride, atropine methyl nitrate, 8-bromo-cGMP, caffeine, catalase, chlorpheniramine maleate, N6,2'-O-dibutyryladenosine 3 ': 5'-cyclic monophosphate (dibutyryl cAMP), EGTA, forskolin, gossypol, 5-HT creatinine sulfate, indomethacin, methylene blue, nitro-L-arginine (L-NNA), nordihydroguaiaretic acid (NDGA), norepinephrine bitartrate, ouabain, pepstatin A, PGF2a, superoxide dismutase (SOD), phosphoramidon, and verapamil hydrochloride. All these drugs were obtained from Sigma Chemical Co., St. Louis, Mo. Furthermore, the following compounds were used: ET-1 (Peptide Institute, Inc.), ketanserin tartrate (Research Biochemicals Inc., Natick, Mass.), BM13505 (Boehringer), phentolamine mesylate (CIBA-GEIGY Corp., Basel, Switzerland), nitroglycerin (Lenitral, Besins-Iscovesco), and perindoprilat (Servier). Stock solutions of the drugs used were prepared not longer than 2 hours before use by dissolving the compounds in distilled water. Exceptions are indomethacin, which was dissolved in an equimolar concentration of Na2CO3; NDGA and pepstatin, which were dissolved in dimethylsulfoxide; caffeine, which was dissolved in PSS; and BM13505, which was dissolved in an equimolar concentration of NaOH. Appropriate dilutions were prepared using the solvents given except for BM13505, which was dissolved with distilled water.
Statistical Analysis
The data are expressed as mean±SEM. For statistical analysis, Student's t test for paired or unpaired observations was used.24 Values ofp <0.05 were considered to be significant.
Results
Effect of Hypoxia on Basal Tension
Hypoxia imposed for 30 minutes did not significantly affect basal tension in control rings with or without endothelium (data not shown). In some atherosclerotic rings, hypoxia caused a weak and transient augmentation of basal tone by 0.6±0.2 g (n=10), which represented 8.1+±2.3% of the contraction induced by KCl (30 mM).
Effect of Hypoxia During Agonist-Induced Contractions
Norepinephrine. Norepinephrine (0.3 uM) contracted control aortas with and without endothelium to 7.3 +0.7 and 7.3+1.1 g, respectively (n=6); the amine evoked significantly smaller contractions in aortas obtained from cholesterol-fed rabbits with and without endothelium (2.7+0.6 and 2.1+0.5 g, respectively; n=6). Figure 1 shows a typical example of the effect of hypoxia in control and atherosclerotic aortas previously contracted with norepinephrine. Hypoxia relaxed the control aorta to a slightly but significantly lesser extent with endothelium than without endothelium (see also Figure 2 ). In atherosclerotic aortas, hypoxia caused a transient but marked enhancement of the contraction (by 41.5+15.4%, n=6; see also Table 1) followed by relaxation; the latter response was slightly smaller than that noted in the control aortas, the level of significance (p<0.05) was reached ( Figure 2 ). Endothelium removal did not alter the responses in the atherosclerotic aortas -E Aortas without endothelium 5 5.3± 1.9 86.1+7.2
Atherosclerotic platelets
Aortas with endothelium 5 6.3±+1.5 84.9±6.9 Aortas without endothelium 5 4.8±1.2 87.0+7.5 Values are mean±SEM taken 30 minutes after the onset of hypoxia. Platelets were used in a final concentration of 3-5 x 107 platelets/ml. No significant differences were noted between the different groups of tissues.
( Figure 2 ). On readmission of oxygen to the bath solution, a return to the normoxic response was noted in both the control and the atherosclerotic aortas ( Figures  1 and 3 ).
Platelets. Platelets (3-5x107 platelets/ml) of control rabbits contracted the control aortas with and without endothelium to 5.1±1.6 (n=4) and 5.3+1.9 g (n=5), respectively, and the atherosclerotic aortas with and without endothelium to 4.1±1.2 (n=5) and 4.7±0.3 g (n=5), respectively. Hypoxia relaxed the control tissues with and without endothelium (Table 2, Figure 3 ) and caused a transient contraction followed by a relaxation of the atherosclerotic tissues with and without endothelium (Figures 3 and 4 ). Similar data were obtained when platelets of hypercholesterolemic rabbits were used to contract both the control and the atherosclerotic aortas (Figure 4 , Table   2 ); in the control aortas with and without endothelium, the initial contractions averaged 6.3±1.5 (n=5) and 4.8±1.2 g (n=5), respectively, whereas in the atherosclerotic aortas with and without endothelium, the initial contractions averaged 4.1 ± 1.3 (n =5) and 4.8+0.5 g (n=5), respectively. and 0.5+0.2 g, respectively). These tissues were completely relaxed by hypoxia (by 102.6+1.4% and 103.5+1.4%, respectively). 5-HT (3 gM) induced a further contraction of control aortas with and without endothelium (4.5 +0.5 and 3.8 +0.7 g, respectively); hypoxia also relaxed these tissues (by 100.2+1.1% and 97.9±+ 1.1%, respectively). In atherosclerotic aortas, 5 -HT (0.3 ,uM) caused a more pronounced contraction with the same concentration of 5 -HT. In the atherosclerotic aortas, hypoxia induced a transient contraction preceding the relaxation ( Figure 5 , Table 1 ).
ET-] and PGF2a. In three control aortas with endothelium, ET-1 (0.03 ,M) and PGF2a (0.3 ,uM) caused contractions that under normoxic conditions averaged 6.0+2.9 and 1.4±0.4 g, respectively. During these responses, hypoxia only caused relaxations (by 85.8±1.3% and 87.8±2.5%, respectively).
In atherosclerotic aortas, the two agonists evoked contractions of comparable amplitude, indicating that contractions to endothelin were significantly smaller than those noted in the control tissues, whereas those to PGF2a were similar ( Table 1) . During these responses, hypoxia caused a transient contraction followed by a relaxation ( Figure 5 ). When expressed as a percentage of the contraction to 30 mM KCl, the hypoxic contraction was less pronounced during contractions caused by ET-1 than during contractions caused by the other agonists ( Table 1 ).
Effect of Hypoxia on WHHL Rabbits
In four aortas obtained from WHHL rabbits, norepinephrine (0.3 ,uM) and 5-HT (0.3 ,uM) evoked stable contractions under normoxic conditions. During these contractions, hypoxia caused a transient further increase in tension followed by a relaxation (Figure 6 , Table 3 ). The hypoxic responses obtained during contractions caused by 5-HT are comparable to those noted in the aortas of the cholesterol-fed rabbits; those obtained during norepinephrine-induced contractions were significantly less ( Table 3) .
Effect ofAntagonists and Inhibitors on the Hypoxic Contractions in Atherosclerosis
Nine atherosclerotic aortas obtained from cholesterol-fed rabbits were exposed twice to 5-HT (0.3 ,M). The first normoxic response to 5-HT averaged 3.3+±0.8 g; the second response increased to 4.8±0.7 g. During the first and second contraction, hypoxia was imposed, causing additional contractions averaging 15.9±3.1% and 15.2±2.6% of the 30 mM KC1 contraction, respectively. Since these hypoxic contractions did not vary significantly with time, the effect of the antagonists and inhibitors was evaluated by administering them before the second response to 5-HT. In some experiments (indicated below), PGF2a was used to cause the initial contraction; this was done when the antagonist and/or inhibitor blocked the 5 -HT-induced response.
Effects of antagonists. The transient hypoxic contractions in the atherosclerotic aortas previously contracted with 5 -HT were not significantly affected by a-adrenergic, muscarinic, histaminergic, or thromboxane receptor antagonists (phentolamine, atropine, chlorpheniramine, and BM13505, respectively) or in tissues previously contracted with PGF2I by the 5-HT2 receptor antagonist ketanserin ( Table 4) .
Effects of inhibitors. The inhibitors of cyclooxygenase (indomethacin) and lipoxygenase (NDGA) or the metalloprotease inhibitors pepstatin, perindoprilat, and phosphoramidon did not alter the hypoxic contraction in the atherosclerotic tissues. Ouabain, which augmented the contractile response to 5-HT, did not significantly affect the hypoxic contraction (Table 5 ). Also, the scavengers of free radicals (SOD and catalase plus SOD), the inhibitor of EDRF (gossypol), and the precursor of EDRF (L-arginine) did not affect the hypoxic contraction in atherosclerosis (Table 5 ). In six atherosclerotic rabbit aortas, the guanylyl cyclase inhibitor methylene blue (10 ,uM) caused a contractile response averaging 3.2±+1.5 g and significantly augmented the contraction caused by 5-HT (Figure 7 ). Also the NO synthase inhibitor L-NNA (100 gtM) caused a significant contraction (0.4±+0.1 g) and potentiated the contraction caused by 5 -HT (Figure 7) in six atherosclerotic aortas. Both inhibitors completely prevented the hypoxic contractions observed in the atherosclerotic arteries (Figure 7) .
Substances influencing Ca 2+ movements. In the atherosclerotic aortas exposed to a Ca2+-free medium containing EGTA (0.1 mM), the normoxic contraction to PGF2, (0.3 ,uM) was significantly diminished, but the transient hypoxic contraction persisted ( Table 6 ). Verapamil (1 ,uM) incubated for 30 minutes did not alter the contraction evoked with PGF2, (0.3 ,uM) in atherosclerosis, and hypoxia under these conditions still caused a transient contraction (Table 6 ).
A series of atherosclerotic arteries treated with verapamil (1 ,uM) were then stimulated with norepineph- rine using concentrations (3-30 ,uM ) that caused contractions comparable to those noted with 0.3 I£M norepinephrine in the absence of verapamil (Table 6) . Under these conditions, the hypoxic contractions evoked in the presence of norepinephrine and verapamil were comparable to those caused in the presence of norepinephrine alone (Table 6 ). In atherosclerotic arteries contracted with norepinephrine in the presence of verapamil, increasing concentrations of caffeine (1-30 ,uM) progressively inhibited the contractions under normoxic conditions. Caffeine also dose-dependently inhibited the hypoxic contraction ( Table 6 ).
Effects of 8-Bromo-cGMP and Dibutyryl cAMP
The effects of 8-bromo-cGMP and dibutyryl cAMP on the hypoxic contractions in atherosclerotic arteries were investigated. 8-Bromo-cGMP (100 pM) markedly decreased the contractions to 5-HT in atherosclerosis. The normoxic contraction to 5 -HT at 3 ,tM in the presence of 8-bromo-cGMP averaged 1.3-+0.2 g (n=6); this value was significantly lower (p<0.05 by Student's t test for paired observations) than that obtained with a concentration of 5-HT 10 times lower (0.3 ,uM) in the absence of 8-bromo-cGMP (2.3 +0.8 g). The presence of 8-bromo-cGMP completely prevented the occurrence of the hypoxic contractions (25.9±4.2% of KCl-induced responses in control conditions, 0% contraction in the presence of the drug); the atherosclerotic aortas now responded to the hypoxic condition with a relaxation (Figure 8 ).
Dibutyryl cAMP (100 ,iM) also significantly reduced the normoxic response to 5 -HT (0.3 ,uM) in the atherosclerotic tissues. To obtain a significant contraction in the presence of dibutyryl cAMP, the concentration of 5-HT was raised to 0.8 gM, causing a contraction of 2.3+±0.7 g (n=8). However, the hypoxic contractions were markedly reduced by the drug and decreased from 23.2±5.3% of the KCl-induced contraction in control conditions to 5.9+2.7% in presence of dibutyryl cAMP (p<0.05 by Student's t test for paired observations). Effects of Hypoxia on Cyclic Nucleotide Levels in Control and Atherosclerotic Aortas cGMP. Experiments performed on control and atherosclerotic aortas with and without endothelium illustrate that over a 30-minute time period, the basal levels of cGMP in the presence of norepinephrine do not significantly vary (Table 7 ). In separate segments obtained from six control aortas, the cGMP levels were measured under normoxic conditions or after exposure to hypoxia during 30 seconds, 3 minutes, or 30 minutes. The results, summarized in Figure 9 , illustrate that under our experimental conditions hypoxia did not significantly modify the cGMP levels. Note, however, that hypoxia tended to cause an initial short-lasting increase in cGMP levels (Table 8, Figure 9 ). In control aortas without endothelium, the cGMP content was significantly lower than that obtained in aortas with endothelium. Hypoxia did not significantly alter the cGMP levels in the aortas without endothelium at any of the time points tested (Table 8 ).
In other segments obtained from the same control aortas with endothelium, acetylcholine (1 ,uM) and nitroglycerin (1 ,uM) both augmented the cGMP levels, whereas forskolin (10 ,uM) had no significant effect Table 9 ). Removal of the endothelium eliminated the effect of acetylcholine, whereas the effect of nitroglycerin remained unaltered (Table 9 ).
In separate segments of five aortas with endothelium obtained from hypercholesterolemic rabbits, the cGMP levels measured under normoxic conditions were markedly lower than those noted in the control aortas (Table  9 ). In these aortas, hypoxia caused an immediate and lasting decrease in the cGMP levels of approximately 30% (Figure 9 ). Comparable results were obtained in atherosclerotic aortas without endothelium (Table 8 ).
In the atherosclerotic aortas with or without endothelium, acetylcholine (1 MM), nitroglycerin (1 ,M), and forskolin (10 ,uM) had no effect on the cGMP levels (Table 9 ).
cAMP. In segments obtained from four control aortas, the cAMP levels were measured under control and normoxic conditions as described above. Under normoxic conditions, the cAMP levels were about six times higher than the cGMP levels. Hypoxia at the points in time checked did not significantly alter the cAMP content of the tissues (Figure 9 ). Forskolin (10 ,uM) markedly augmented the cAMP levels; nitroglycerin (1 ,.M) caused a small but significant increase, whereas acetylcholine (1 ,uM) had no effect ( Table 9 ). Removal of the endothelium had no significant effect on the cAMP content of the control aortas (1,342±157 pmol/g protein in tissues with endo-thelium and 1,303 + 122 pmol/g protein in tissues without endothelium). In segments obtained from four atherosclerotic aortas, the cAMP content under normoxic conditions was significantly lower than that obtained in the control tissues (Tables 9 and 10). Hypoxia did not significantly alter the cAMP levels of the atherosclerotic aortas (Table 10) . Forskolin (10 ,uM) still increased the cAMP content of the atherosclerotic aorta but to a lesser extent than the control value (Table 9 ); neither acetylcholine nor nitroglycerin significantly altered the cAMP levels in the aortas of the cholesterol-fed rabbits ( Table 9 ). Discussion The major findings of our present study can be summarized as follows: 1) Severe hypoxia causes a transient contraction in aortas obtained from cholesterol-fed rabbits. Such a contractile response is absent in control aortas, where hypoxia only causes relaxation. 2) The hypoxic contraction could also be shown in aortas of the WHHL rabbit. 3) The hypoxic contraction in atherosclerosis is endothelium independent and occurs in aortas preconstricted with different agonists including aggregating platelets. 4) The hypoxic contraction in atherosclerosis is insensitive to a variety of classical antagonists and inhibitors (see below) but ultimately depends on the availability of intracellular Ca2`. 5 cGMP production of the atherosclerotic aorta both with and without endothelium; it can be prevented by augmenting the intracellular level of cGMP. It can also be prevented by inhibition of guanylyl cyclase, which by itself causes contraction. 6) A reduced production of NO by nonendothelial cells may be responsible for the hypoxic contraction in atherosclerosis. Inhibition of NO synthase, which by itself causes contraction in the atherosclerotic aorta, prevented the hypoxic contraction. 7) Our experiments reconfirm the markedly reduced production of cGMP in atherosclerosis; they also demonstrate a substantial inhibition of the cAMP production in the atherosclerotic aorta. However, changes in cAMP production do not seem to be implicated in the hypoxic contraction. Atherosclerosis influences the contractile properties to some vasoconstrictor agents; in particular, it can augment the contractile potency of 5 4H1,3,18,25 while decreasing that to norepinephrine, for example. Severe tissue hypoxia is a consequence of the progressive narrowing of the arterial wall by a growing atherosclerotic plaque. If obstruction occurs, usually a$ a result of the formation of a thrombus over the plaque, a complete impairment of tissue function may result from the hypoxia. At the site of an atherosclerotic plaque, the nourishment of the vessel wall may be partially compromised, and in particular, local tissue hypoxia m4ay occur. Although the effects of hypoxia on vascular reactivity have been frequently studied (see below), to our knowledge, the action of hypoxia in atherosclerotic blood vessels has not yet been reported. Therefore, we selected the aorta obtained from the cholesterol-fed rabbit as a model of an atherosclerotic artery. So far, several important changes in vascular reactivity reported to occur in the coronary arteries, for example, have also been shown in the atherosclerotic rabbit aorta (for reviews see References 1 and 2). The cholesterol diet used in the present study caused a marked augmentation of the plasma cholesterol levels and a development of fatty streaks at the level of the thoracic aorta, and these data are in complete agreement with earlier findings." 3'4 It is well known that the mechanical tension of isolated vascular smooth muscle preparations is sensitive to variations in the organ bath oxygen tension. The nature of the oxygen sensor is still unknown.26-28 Depending on the anatomic origin and/or the species used, severe hypoxia, sometimes denoted as anoxia, can cause either relaxation or further contraction of isolated arteries and veins with preexisting tone.29 The mechanisms by which hypoxia depresses the reactivity of Normoxic levels average 220±31 pmol/g protein in control tissues and 67+21 pmol/g protein in the atherosclerotic tissues. Note the initial (nonsignificant) increase in cGMP production in the control aortas. In atherosclerotic aortas, hypoxia reduced the cGMP levels. *Significant decrease from normoxic levels (p<0.05 by Student's t test for paired observations). o N0* HYPOXA isolated arteries to vasoactive agents may relate to processes at the vascular smooth muscle cell level such as inhibition of energy supply for the contractile process or to indirect factors such as the liberation of relaxing factors from the endothelium or inhibition of norepinephrine release.30-32 On the other hand, hypoxia can cause contraction of isolated arteries, which may relate to liberation of vasoconstrictor substances from the endothelium such as cyclooxygenase metabolites and endothelin28293334 or to an augmentation of norepinephrine release. 35, 36 Aortas isolated from control rabbits have been used repeatedly to study the influence of changes in oxygen tension on vascular contractility. Earlier studies illustrated that changes in oxygen pressure between 1 and 675 mm Hg do not alter basal tension of the isolated rabbit aorta37 and that hypoxia decreases the contractile responses to catecholamines and other vasoconstrictors. 38 It was suggested that the energy metabolism in the rabbit aorta is supported by oxidative pathways and ATP supply to the contractile process38; it was also shown that the loss of contractile tone caused by hypoxia is not directly attributable to a deficit in the availability of ATP but, rather, is a consequence of subtle alterations in energy metabolism of the vascular smooth muscle. 39 Also, a reduced entry of extracellular Ca2' has been proposed as a mechanism for the hypoxic relaxation.40 More recent studies, taking into account the role of the endothelium in vascular relaxation (see Reference 41) , illustrate that the hypoxic relaxation in the rabbit aorta is only minimally dependent on the presence of an intact endothelium.2731
All these observations are confirmed by the present study, which shows that indeed the control rabbit aorta relaxes when hypoxia is imposed during a sustained contraction and that this relaxation is only minimally dependent on the presence of the endothelium; the endothelium dependency of the hypoxic relaxation was only visible in tissues precontracted with norepinephrine.
Our data give some information on a possible influence of hypoxia on the production of cyclic nucleotides in control rabbit aortas. Most vascular smooth muscle relaxations depend on the production of cAMP or cGMP. However, some studies have illustrated that hypoxia decreases the levels of the intracellular messengers; thus, cGMP levels were reported to be decreased in the rabbit aorta27 and the rabbit carotid body,42 and pulmonary cAMP levels were found to be decreased in rats. 43 The small decrease in the cGMP production during hypoxia in the rabbit aorta was only detected at a time when the tissues relaxed by 40% and when the Po2 was 100 mm Hg. 27 In general, our results seem to indicate that no changes in the production of cGMP and cAMP occur during hypoxia in the rabbit aorta. However, there was a tendency for an initial short-lasting increase in the cGMP production at the onset of the hypoxic response only when the endothelium was present; this increase is small and did not reach statistical significance. If it can be confirmed, we suggest that it may be related to the small part of the hypoxic response that depends on the presence of the endothelium. Indeed, the cGMP production measured in the control aortas seems to depend to a major extent on the endothelial NO production since it was substantially reduced when the endothelium was removed in confirmation of earlier findings (see Reference 41) . The cAMP production was not altered by endothelium removal.
An important difference between the hypoxic responses in control and atherosclerotic rabbit aortas was that the latter tissues always responded with an initial transient contraction (lasting 3-10 minutes) before the normal relaxation occurred. Such a hypoxic contraction in atherosclerosis has, to our knowledge, not yet been reported. In a certain percentage of aortas obtained from the cholesterol-fed rabbits, the hypoxic contraction occurred in the absence of preexisting tone; however, this response was very variable and relatively small so that it seemed logical to further analyze the hypoxic responses in precontracted atherosclerotic aortas.
The abnormal hypoxic contraction was detected in aortas contracted with norepinephrine, 5 -HT, platelets, PGF2a, or ET-1. Although initial contractions with variable amplitudes were used, the hypoxic contractions were always present and always averaged approximately 20% of the contraction induced by 30 mM KCI; the latter is approximately the maximal response that can be obtained in the rabbit aorta. If tissues were first contracted with ET-1, the hypoxic contraction was significantly smaller. Finally, the hypoxic contractions were also observed in a genetic model of atherosclerosis, the WHHL rabbit.
The relaxations in the aortas of the cholesterol-fed rabbits were significantly smaller than those noted in the control aortas; this was especially true during contractions evoked with norepinephrine. Two factors can help to explain this decreased response: the hypoxic contraction that precedes the relaxation can in part prevent the relaxation, and/or the small contribution of EDRFs to the overall hypoxic relaxation may be reduced in atherosclerosis. However, the effect of atherosclerosis on the hypoxic relaxation is moderate and cannot be compared with, for example, the complete inhibition of endothelium-dependent relaxations caused by the disease (see Reference 1) .
After documenting the hypoxic contraction in atherosclerosis, we attempted to evaluate possible mechanisms that could underlie this abnormal response. We first investigated the possible contribution of some "classical" neurotransmitters and/or vasoconstrictors. When used in concentrations known to antagonize a-adrenoceptors, muscarinic receptors, histaminergic receptors, 5-HT2 receptors, and thromboxane A2/endoperoxide receptors and to inhibit the production of cyclooxygenase and lipoxygenase metabolites of arachidonic acid, the respective antagonists phentolamine,44 atropine,45 chlorpheniramine,46 ketanserin,47 and BM1350548 and the respective inhibitory agents indomethacin44A4950 and NDGA50 did not significantly alter the hypoxic contraction in atherosclerosis. Except for chlorpheniramine, all the antagonists have been shown to be effective in atherosclerotic preparations, and the references given indicate such studies. Thus, neither an augmented liberation of norepinephrine shown to occur with hypoxia in some vascular tissues,3536 nor the liberation of 5-HT shown to occur in coronary artery endothelial cells with hypoxia,51 nor the production of constrictor arachidonic acid metabolites such as endoperoxides, thromboxane, and hydroxyeicosatetraenoic acids48,52,53 explains the abnormal hypoxic contraction. Also, ouabain, which was illustrated to prevent the endothelium-dependent contraction to hypoxia in canine coronary arteries28 or the production of free radicals that were illustrated to be involved in endothelium-dependent contractions in cerebral arteries,54 did not modify the hypoxic contractions noted in the atherosclerotic arteries. The concen-used in studies of atherosclerotic pig coronary arteries and atherosclerotic monkey femoral arteries. 49, 50 Endothelin has recently been proposed as a very powerful endothelium-derived vasoconstrictor factor.55 Although several experimental data discussed above indicate that the endothelium is not involved in the hypoxic contraction observed in the atherosclerotic aorta and that endothelin is not the endotheliumderived contracting factor released during anoxia,56 we did consider a possible involvement of endothelin, because recent evidence suggests that this constrictor peptide can also be produced by other cells, such as vascular smooth muscle cells.57 Moreover, inhibitors of metallopeptidases, such as pepstatin and phosphoramidon, were shown to inhibit the endothelin production by blocking the conversion of big endothelin to endothelin.5859 When used in concentrations that block the production of endothelin in endothelial cells, neither pepstatin nor phosphoramidon significantly altered the hypoxic contractions in the atherosclerotic aorta, and these experiments seem to exclude endothelin as a possible mediator of this abnormal response. Another inhibitor of metallopeptidases, the converting enzyme inhibitor perindoprilat,60 also didn't block the hypoxic contraction, suggesting that neither angiotensin II nor bradykinin are involved.
The possibility exists that hypoxia causes its contractile effect in atherosclerotic arteries independent of the release of a constrictor substance, for instance by interacting directly at the level of second messenger systems or Ca> fluxes. Therefore, we performed preliminary experiments to test these possibilities.
Influx of external Ca> does not seem to be the cause of the hypoxic contraction, since neither Ca`4-free medium nor the inhibitor of Ca' influx, verapamil,6' significantly affected the abnormal response to hypoxia in atherosclerosis. However, when increasing concentrations of caffeine, a blocker of intracellular Ca>`,62 were used in combination with the blockade of external Ca>2 influx, the hypoxic contractions could be inhibited, suggesting that they ultimately depend on the availability of Ca`. In this respect, the hypoxic contraction in atherosclerosis differs from the anoxic endotheliumindependent contraction in the canine saphenous vein that could be blocked by verapamil63 and from the anoxic endothelium-dependent contraction in the canine coronary artery that could also be inhibited by Ca2-entry blockers and by a Ca2-free medium64; the latter two hypoxic responses depend on the influx of extracellular Ca>2. Although the data with caffeine may indicate the involvement of Ca> in the development of the hypoxic contraction, it should be noted that caffeine can cause relaxation of vascular tissues by an unknown mechanism that may not relate to Ca>2 fluxes.62 Another possibility to explain differences between the control aorta and the atherosclerotic aorta is that the oxygen profile within the arterial wall could be different. Although this possibility remains to be explored, it should be noted that we never obtained hypoxic contractions in the control aortas.
Finally, it could be argued that the hypoxic contraction occurs because the atherosclerotic tissues show an enhanced sensitivity to some of the vasoconstrictor agents used. In favor of this argument is an earlier study trations of SOD and catalase used were similar to those 65 by Peach et al, who found hypoxic contractions in control aortas especially under conditions of elevated tone. Under the current experimental conditions, we did not find such contractions, in agreement with studies done by Coburn et al.27 Moreover, the hypoxic contraction in atherosclerosis seemed to occur under different levels of initial tone. Some hypoxic contractions have been attributed to a decreased production of cGMP. Thus, the hypoxic pulmonary constriction in cats evoked a decreased cGMP level in the pulmonary artery. 66 In the pulmonary artery 8-bromo-cGMP nearly completely inhibited the hypoxic endothelium-dependent contraction. 67 In a first attempt to gain some information about the intracellular messengers cAMP and cGMP, we tested their penetrable analogues dibutyryl cAMP and 8-bromo-cGMP on the hypoxic contractions in atherosclerosis. Both compounds were able to inhibit the hypoxic contraction, with 8-bromo-cGMP being more potent. These data then suggested that a decreased production of the second messengers involved in smooth muscle relaxation might be implicated in the occurrence of the hypoxic contraction.
To verify this hypothesis, we compared the production of both cGMP and cAMP in aortas of control and cholesterol-fed rabbits under different experimental conditions. The present data confirm that removal of the endothelium from the control aortas markedly reduces the basal levels of cGMP and abolishes the increased release caused by acetylcholine but not that caused by nitroglycerin. Our data with cGMP also confirm those of a previous study7 illustrating a markedly reduced production of cGMP in atherosclerosis. The basal levels of cGMP were very low in the atherosclerotic aorta, and at our stage of the disease process, nitroglycerin (1 ,gM) and acetylcholine (1 ,uM) failed to cause any increase in cGMP production. Removal of the endothelium from the atherosclerotic aortas did not further affect either the basal or the stimulated cGMP production. These data are in agreement with our earlier findings showing the absence of endotheliumdependent relaxation to acetylcholine in advanced atherosclerosis and markedly reduced responsiveness to nitroglycerin and NO. 34 The present study also reveals a significantly reduced basal and forskolin-stimulated production of cAMP in the atherosclerotic aorta. However, the decrease in cAMP production is less pronounced than the decrease in cGMP production.
Hypoxia caused a profound reduction in the production of cGMP in the atherosclerotic aorta both in the presence and absence of the endothelium. This observation confirms the data with 8-bromo-cGMP and strongly suggests that the reduced cGMP production is the cause of the hypoxic contraction. Further evidence supporting this interpretation was obtained with the inhibitor of guanylyl cyclase, methylene blue (see Reference 41). This agent caused contraction of the atherosclerotic aorta, enhanced the contractile response to 5 -HT, but at the same time prevented the occurrence of the hypoxic contraction. The most likely explanation for these findings is that methylene blue and hypoxia have the same mechanism of action, i.e., to inhibit guanylyl cyclase.
Hypoxia did not significantly alter the cAMP production in atherosclerosis. This observation contrasts with the data showing restoration of the normal response to hypoxia with dibutyryl cAMP. Further experiments are needed to clarify these conflicting results, but one explanation may be that the action of dibutyryl cAMP is not selective.
Our findings offer an explanation for the difference in responsiveness to hypoxia between control and atherosclerotic aortas. Indeed, in the control tissue, hypoxia, if anything, tends to cause an initial augmentation of the cGMP production. At the same time, in the atherosclerotic aorta, a rapid significant decrease in cGMP production occurs favoring contraction in a tissue in which the basal cGMP levels are already very low.
So, a reduction in the formation of cGMP and thus in the activity of guanylyl cyclase seems to be the final step by which hypoxia causes contraction in the atherosclerotic aorta. This could be due to a direct inhibitory effect of hypoxia on the guanylyl cyclase or to an inhibitory effect on the production of NO, the endogenous activator of guanylyl cyclase.41 Our present data together with earlier studies seem to exclude a possible involvement of endothelium-derived NO. Indeed, the hypoxic contraction is not endothelium dependent and in the atherosclerotic rabbit aorta, NO is no longer active,4 whereas the endothelium-derived NO that is still produced does not reach its target3 (also see References 1 and 2). Recent evidence indicates that NO synthase is not only present in endothelial cells but also in platelets, nervous tissue, macrophages, neutrophils, and even smooth muscle cells (see Reference 68) . In the latter cells, the NO synthase is of the inducible type, and NO may be formed in these cells as a response to inflammatory stimuli such as interleukins (see Reference 68).
Atherosclerosis is a complex process implicating, for example, infiltration of monocytes into the vascular wall, and it has been proposed repeatedly that the atherosclerotic vascular disease has some features in common with chronic inflammation. 69 It could be that in atherosclerotic blood vessels NO synthase is induced either in macrophages or in the smooth muscle cells. If NO thus formed were to participate in maintaining the atherosclerotic tissues in a state of relaxation, then inhibitors of its synthesis, such as L-arginine analogues,70 should have an effect. Our data illustrate that L-NNA contracts the atherosclerotic aorta, enhances the contraction to 5-HT, and prevents the hypoxic contraction. Thus L-NNA and hypoxia may have the same action, i.e., blocking NO synthase in nonendothelial cells of the atherosclerotic vascular wall. It should be noted that we did not find in our study a significant effect of gossypol, also described as an inhibitor of EDRF,7' probably because this substance interferes more with NO transfer from the endothelium to the smooth muscle cells. A similar reason may be given for the absence of effect of SOD. Finally, L-arginine alone was not able to restore the normal hypoxic relaxation in the atherosclerotic tissues.
However, we believe that our data using the specific NO synthase inhibitor L-NNA offer the best evidence for implicating the inhibition of NO synthase in the hypoxic contraction. Moreover, the fact that both L-NNA and methylene blue significantly augment the contractile responses to 5-HT as they do those to norepinephrine (data not shown) suggests that the nonendothelial production of NO may be responsible for the decreased responses to some agonists in atherosclerotic arteries3 (also see References 1 and 2). Some evidence is available favoring our conclusions. Thus, in the rat pulmonary artery an inhibition of the endothelium-dependent hypoxic contraction was observed on the administration of NO to the tissues. 67 During the editorial process of the present article, a manuscript was published illustrating that a moderate decrease of the cGMP level in vascular smooth muscle is a prerequisite for the occurrence of hypoxia-induced facilitation in contracted canine coronary arteries. 72 In conclusion, our data are the first demonstration of an abnormal hypoxic contraction that occurs in the aorta of cholesterol-fed and WHHL rabbits. This hypoxic contraction mnost likely results from a decreased ability of the atherosclerotic smooth muscle cells to produce cGMP, and the latter effect may involve a reduced production of nonendothelial NO.
Our data suggest that hypoxia that occurs as a result of vasospasm at the site of atherosclerotic plaques can reinforce the tissue contraction, thereby possibly aggravating vasospasm. Hypoxia in conjunction with the loss of endothelium-dependent relaxation will further drive the diseased arterial wall to a state of constriction.
